Silvia van der Flier | Medical Advisor
VGZ

Silvia van der Flier is a dedicated and experienced Medical Advisor at VGZ, a leading healthcare insurance provider. With a background in medicine and a passion for improving patient outcomes, Silvia plays a crucial role in shaping healthcare policies and strategies within the orphan drug industry. Her expertise lies in advocating for access to innovative treatments for rare diseases, ensuring that patients receive the care they deserve.

Silvia's commitment to the orphan drug industry is evident in her strategic approach to partnering with key stakeholders, including pharmaceutical companies, healthcare providers, and patient advocacy groups. By fostering collaborations and driving initiatives that support orphan drug development and access, she is at the forefront of advancing the field and making a difference in the lives of patients with rare diseases.

With a strong foundation in medical research and a deep understanding of the complexities of the healthcare system, Silvia brings a unique perspective to her role at VGZ. Her ability to navigate regulatory challenges, identify opportunities for growth, and drive impactful change sets her apart as a thought leader in the orphan drug industry.

Silvia van der Flier's participation at the World Orphan Drug Congress 2025 is a testament to her expertise and leadership in the field. As a speaker, she will share valuable insights on strategy, advocacy, and partnering for the orphan drug industry, inspiring others to join the mission of improving access to life-changing treatments for rare diseases.